Exclusive Content:

Emerging Biosimilars and the Importance of Identifying Experienced Providers

Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year. Read more about how Biologics and Biosimilars help fight chronic disease as well as the difference between Generics and Biosimilars.

Download Emerging Biosimilars and the Importance of Identifying Experienced Providers Whitepaper

emerging-biosimilars-and-the-importance-of-identifying-experienced-providers

Latest

The future of manufacturing with generative AI

Discover how Amazon Web Services (AWS) can help your...

Unlocking the full potential of RWD with insights from real-time EHR data

Timely data are critical for life sciences and healthcare...

The Benefits of Network Monitoring for Industrial Digitalization

Manufacturing is powered by thousands of connected devices, massive...

Newsletter

Don't miss

The future of manufacturing with generative AI

Discover how Amazon Web Services (AWS) can help your...

Unlocking the full potential of RWD with insights from real-time EHR data

Timely data are critical for life sciences and healthcare...

The Benefits of Network Monitoring for Industrial Digitalization

Manufacturing is powered by thousands of connected devices, massive...